• 2985 Citations
  • 33 h-Index
20102019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Cristian Rodriguez-Aguayo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Ovarian Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
MicroRNAs Medicine & Life Sciences
Tumors Chemical Compounds
Small Interfering RNA Medicine & Life Sciences
Growth Medicine & Life Sciences
Cells Chemical Compounds
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2010 2019

Corrigendum: FOXM1 mediates Dox resistance in breast cancer by enhancing DNA repair

Park, Y. Y., Jung, S. Y., Jennings, N. B., Rodriguez-Aguayo, C., Peng, G., Lee, S. R., Kim, S. B., Kim, K., Leem, S. H., Lin, S-Y., Lopez, G., Sood, A. K. & Lee, J-S., Jul 20 2019, In : Carcinogenesis. 40, 7, 1 p.

Research output: Contribution to journalComment/debate

Open Access
DNA Repair
Breast Neoplasms
corrigendum

GnRH-R-Targeted lytic peptide sensitizes BRCA wild-type ovarian cancer to PARP inhibition

Ma, S., Pradeep, S., Villar-Prados, A., Wen, Y., Bayraktar, E., Mangala, L. S., Kim, M. S., Wu, S., Hu, W., Rodriguez-Aguayo, C., Leuschner, C., Liang, X., Ram, P., Schlacher, K., Coleman, R. & Sood, A. K., Jan 1 2019, In : Molecular cancer therapeutics. 18, 5, p. 969-979 11 p.

Research output: Contribution to journalArticle

Gonadotropin-Releasing Hormone
Ovarian Neoplasms
Peptides
Protein Array Analysis
Comet Assay

Identifying and targeting angiogenesis-related microRNAs in ovarian cancer

Chen, X., Mangala, L. S., Mooberry, L., Bayraktar, E., Dasari, S. K., Ma, S., Ivan, C., Court, K. A., Rodriguez-Aguayo, C., Bayraktar, R., Raut, S., Sabnis, N., Kong, X., Yang, X., Lopez, G., Lacko, A. G. & Sood, A. K., Aug 15 2019, In : Oncogene. 38, 33, p. 6095-6108 14 p.

Research output: Contribution to journalArticle

MicroRNAs
Ovarian Neoplasms
Neoplasms
CD36 Antigens
Vascular Endothelial Growth Factor A

Predicting novel therapies and targets: Regulation of Notch3 by the bromodomain protein Brd4

Villar-Prados, A., Wu, S., Court, K. A., Ma, S., LaFargue, C., Chowdhury, M. A., Engelhardt, M. I., Ivan, C., Ram, P., Wang, Y., Baggerly, K. A., Rodriguez-Aguayo, C., Lopez, G., Yang, S. M., Maloney, D. J., Yoshioka, M., Strovel, J. W., Roszik, J. & Sood, A. K., Feb 1 2019, In : Molecular cancer therapeutics. 18, 2, p. 421-436 16 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Small Interfering RNA
Therapeutics
Down-Regulation
Neoplasms
3 Citations (Scopus)

PRKRA/PACT expression promotes chemoresistance of mucinous ovarian cancer

Hisamatsu, T., McGuire, M., Wu, S., Rupaimoole, R., Pradeep, S., Bayraktar, E., Noh, K., Hu, W., Hansen, J. M., Lyons, Y. A., Gharpure, K. M., Nagaraja, A. S., Mangala, L. S., Mitamura, T., Rodriguez-Aguayo, C., Eun, Y. G., Rose, J., Bartholomeusz, G., Ivan, C., Lee, J-S. & 5 others, Matsuo, K., Frumovitz, M., Wong, K. K., Lopez, G. & Sood, A. K., Jan 1 2019, In : Molecular cancer therapeutics. 18, 1, p. 162-172 11 p.

Research output: Contribution to journalArticle

oxaliplatin
Ovarian Neoplasms
Small Interfering RNA
Platinum
Phosphotransferases